Filing Details

Accession Number:
0000947871-13-000521
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-07-17 19:20:58
Reporting Period:
2013-07-15
Filing Date:
2013-07-17
Accepted Time:
2013-07-17 19:20:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1326583 Webmd Health Corp. WBMD Services-Business Services, Nec (7389) 202783228
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1230617 E Joseph Smith 111 Eighth Avenue
New York NY 10011
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-07-15 8,888 $20.23 48,217 No 4 M Direct
Common Stock Acquisiton 2013-07-15 8,888 $18.37 57,105 No 4 M Direct
Common Stock Acquisiton 2013-07-15 8,888 $19.04 65,993 No 4 M Direct
Common Stock Disposition 2013-07-15 26,664 $32.04 39,329 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2013-07-15 8,888 $0.00 8,888 $20.23
Common Stock Stock Option (Right to Buy) Disposition 2013-07-15 8,888 $0.00 8,888 $18.37
Common Stock Stock Option (Right to Buy) Disposition 2013-07-15 8,888 $0.00 8,888 $19.04
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2009-10-23 2014-01-01 No 4 M Direct
0 2009-10-23 2015-01-01 No 4 M Direct
0 2016-01-01 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.04 to $32.06 inclusive. The reporting person undertakes to provide to WebMD Health Corp., any security holder of WebMD Health Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.
  2. 25% of the shares underlying the option vested on the first anniversary of the grant date and 1/48 of the shares vested monthly thereafter over the next three-year period (fully vested on the 4th anniversary of the grant date). The date of grant for the option was ten years prior to the expiration date.